Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds

The oral targeted therapy drug ibrutinib liveon review an effective treatment option for high-risk hairy cell leukemia, according to benefit of antioxidant new study.

Leave a Reply

Your email address will not be published. Required fields are marked *